Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell
NCT06441344
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
136
Enrollment
OTHER
Sponsor class
Conditions
SCLC
Maintenance Treatment
Interventions
DRUG:
Toripalimab plus Anlotinib
DRUG:
Toripalimab
Sponsor
Taizhou Hospital